SWS Enhancement Program

About AstronauTx

AstronauTx is pioneering a disease-modifying strategy for neurodegenerative disorders by targeting the fundamental link between sleep dysregulation and cognitive decline. The company's platform aims to pharmacologically enhance slow wave sleep and its associated slow oscillations, which are critical for memory consolidation and the brain's waste clearance system (glymphatic flow). Backed by experienced leadership from the biotech and pharma sectors and investors like the SV Health Investors' Dementia Discovery Fund, AstronauTx is advancing its pipeline with the goal of slowing cognitive decline in early-stage Alzheimer's disease and other conditions.

About AstronauTx

AstronauTx is pioneering a disease-modifying strategy for neurodegenerative disorders by targeting the fundamental link between sleep dysregulation and cognitive decline. The company's platform aims to pharmacologically enhance slow wave sleep and its associated slow oscillations, which are critical for memory consolidation and the brain's waste clearance system (glymphatic flow). Backed by experienced leadership from the biotech and pharma sectors and investors like the SV Health Investors' Dementia Discovery Fund, AstronauTx is advancing its pipeline with the goal of slowing cognitive decline in early-stage Alzheimer's disease and other conditions.

Therapeutic Areas